|
?:abstract
|
-
SARS-CoV-2 causes the disease named COVID-19, which emerged in Wuhan, China, in December 2019 and developed into the current pandemic The manifestations of SARS-CoV-2 infection are highly variable The worst outcomes are usually associated with advanced age and known risk factors Among these, it would be reasonable to consider conditions compromising the immune system, particularly the immunodeficiency associated to HIV To date, however, there is no evidence of HIV infection worsening the evolution and prognosis of COVID-19 Pneumocystis jirovecii (previously-P carinii) pneumonia, is a fungal disease that most commonly affects immunocompromised persons and can be life-threatening Typically, patients at risk are those with any underlying condition altering host immunity We present the case of a middle-aged woman with Raynaud\'s syndrome who was admitted with pneumonia During hospitalization she was simultaneously diagnosed with infection by HIV, COVID-19 and P jirovecci The patient evolved favorably upon empirical treatment without requiring invasive maneuvers or ventilatory support Outpatient follow-up after hospital discharge was uneventful
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}